Share Twitter LinkedIn Facebook Email Alok Khorana, MD of the Cleveland Clinic discusses the prevalence and consequences of VTE and increased chance of fatality and admissions to the hospital at the 2017 American Society of Hematology.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read